HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support
Journal of Cardiac Failure · 2023
DOI: 10.1016/j.cardfail.2023.01.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiac Failure, 2023. Verfasst von Barry Trachtenberg und 9 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist Heart and Vascular Center, Methodist J.C. Walter Transplant Center, Houston, Texas. Electronic address: btrachtenberg@houstonmethod…. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 172 Literaturangaben.
Abstract (Originalsprache)
The medical management of patients supported with durable continuous flow left ventricular assist device (LVAD) support encompasses pharmacological therapies administered in the preoperative, intraoperative, postoperative, and chronic LVAD support stages. As patients live longer on LVAD support, the risks of LVAD-related complications and progression of cardiovascular and other diseases increase. Using existing data from cohort studies, registries, randomized trials, and expert opinion, this Heart Failure Society of America Consensus Document on the Medical Management of Patients on Durable Mechanical Circulatory Support offers best practices on the management of patients on durable mechanical circulatory support, focusing on pharmacological therapies administered to patients on continuous flow LVADs. Although quality data in the LVAD population are few, the use of guideline-directed heart failure medical therapies and the importance of blood pressure management, right ventricular preload and afterload optimization, and antiplatelet and anticoagulation regimens are discussed. Recommended pharmacological regimens used to mitigate or treat common complications encountered during LVAD support, including arrhythmias, vasoplegia, mucocutaneous bleeding, and infectious complications, are addressed. Finally, this document touches on important potential pharmacological interactions from antidepressants and herbal and nutritional supplements of relevance to providers of patients on LVAD support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Houston Methodist Heart and Vascular Center, Methodist J.C. Walter Transplant Center, Houston, Texas. Electronic address: btrachtenberg@houstonmethodist.org.
- Mechanical Circulatory Support Program, Cardiac Critical Care, Henry Ford Advanced Heart Failure Program, Detroit, Michigan.
- New York-Presbyterian Hospital, Columbia University Medical Center, New York, New York.
- Henry Ford Hospital, Detroit, Michigan.
- Spectrum Health, Grand Rapids, Michigan.
- University of Minnesota, Minneapolis, Minnesota.
Zitieren
APA
Trachtenberg, B., Cowger, J., Jennings, D. L., Grafton, G., Loyaga-Rendon, R., Cogswell, R., Klein, L., Shah, P., Kiernan, M., & Vorovich, E. (2023). HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2023.01.009
Vancouver
Trachtenberg B, Cowger J, Jennings DL, Grafton G, Loyaga-Rendon R, Cogswell R, et al. HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support. Journal of Cardiac Failure. 2023. doi:10.1016/j.cardfail.2023.01.009
BibTeX
@article{Trachtenberg2023,
author = {Trachtenberg, Barry and Cowger, Jennifer and Jennings, Douglas L and Grafton, Gillian and Loyaga-Rendon, Renzo and Cogswell, Rebecca and Klein, Liviu and Shah, Palak and Kiernan, Michael and Vorovich, Esther},
title = {HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support},
journal = {Journal of Cardiac Failure},
year = {2023},
doi = {10.1016/j.cardfail.2023.01.009}
}
EUVIMED